|
|||||
![]() |
|
Environmental services provider Montrose (NYSE:MEG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 35.3% year on year to $234.5 million. The company’s full-year revenue guidance of $815 million at the midpoint came in 7% above analysts’ estimates. Its non-GAAP profit of $0.63 per share was significantly above analysts’ consensus estimates.
Is now the time to buy MEG? Find out in our full research report (it’s free).
Montrose’s second quarter results were well received by the market, reflecting both a significant revenue beat and substantial year-on-year growth. Management pointed to robust client demand across all three business segments and highlighted the impact of a large-scale environmental emergency response for an energy client as a driver of quarterly results. CEO Vijay Manthripragada emphasized that the company’s integrated model and focus on recurring environmental science-based services enabled broad margin improvement, while the balance between organic growth and contributions from prior acquisitions supported overall momentum. Notably, management credited cross-selling efforts and increased client retention as key contributors to performance.
Looking forward, Montrose’s updated guidance is shaped by expectations of continued strong organic growth, margin expansion, and sustained client demand for environmental science solutions. Management outlined that ongoing regulatory complexity at the state and international level is likely to sustain demand, even as federal rules fluctuate. CEO Vijay Manthripragada stated, “Our focus on cash flow generation, balance sheet simplification, and scalable profitability will allow us to drive value, regardless of regulatory or macroeconomic changes.” The company remains optimistic about further leveraging its technology portfolio and deepening relationships with existing clients to support growth into next year.
Management attributed the quarter’s outperformance to a combination of emergency response activity, steady organic growth across all segments, and improved operating leverage, while noting that client diversification and regulatory trends played a supporting role.
Montrose expects ongoing organic growth, regulatory-driven demand, and margin expansion to underpin its guidance for the remainder of the year.
In the coming quarters, the StockStory team will watch (1) the pace at which emergency response contracts convert into recurring remediation and consulting work, (2) the sustained strength of organic growth across all segments as regulatory drivers evolve, and (3) evidence of margin expansion as the company leverages its integrated service model and technology investments. Additional attention will be paid to Montrose’s ability to resume disciplined M&A and to further diversify its environmental services portfolio.
Montrose currently trades at $26.27, up from $22.61 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
13 hours | |
Sep-10 | |
Sep-09 | |
Sep-09 | |
Sep-08 | |
Sep-08 | |
Sep-04 | |
Sep-02 | |
Aug-29 | |
Aug-29 | |
Aug-28 | |
Aug-27 | |
Aug-27 | |
Aug-25 | |
Aug-21 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite